This brief review will summarise our present knowl edge on the possible role of human minor histocom patibility antigens (mHags) in graft failure. Following a short introduction on the possible nature of human mHags some in vitro studies dealing with graft failure and rejection will be discussed. To understand the possible impact of mHag disparity between organ donor and recipient on the outcome of organ and bone marrow (BM) grafting, information on their tissue expression is essential; hence a summary is given on the mHag tissue distribution studies performed so far. Finally, we will present our preliminary studies on the expression of mHag on human corneal tissue.
POSSIBLE NATURE OF HUMAN mHag
mHags are most probably naturally processed peptides of cytosolic proteins. 1 ,2 The MHC restricted presentation of mHag peptides on the cell surface requires peptide import by an ABC transporter dependent system into the endoplasmic reticulum, where they bind to newly sensitised MHC molecules? In the clinical setting of organ and BM transplantation between HLA matched, mHags mismatched individuals, the mHags are capable of inducing vigorous immune responses leading to graft rejection or graft-versus-host disease. 4 -6 The male specific H-Y is by far the simplest and also the most extensively studied mHag. The first report on H-Yas a transplantation antigen is an untitled communica tion by Eichwald and Silmser in 1955. These authors observed that within two inbred strains of mice, most of the male-to-female skin grafts were rejected, whereas transplants made in other sex combinations retrospective study showed that HLA-A2 females receiving HLA-A2 male kidneys survived for a significantly shorter time than did non-HLA-A2 male kidneys in non-HLA-A2 female recipients. 1 6 mHag TISSUE DISTRIBUTION STUDIES Naturally the impact of mHags on the outcome of organ and BM grafting is dependent on, amongst other things, their tissue distribution. Table II summarises the tissues and cells studied to date. We observed ubiquitous versus restricted tissue distribu tion of the mHags analysed. 1 7 Expression of the non sex-linked mHags, i.e. HA-l, -2 and _5, 1 7 is restricted to the haematopoietic cell lineage including epider mal-derived Langerhans cells, 1 8 whereas H-Y, HA-3 and HA-4 were found to be expressed on cells of all tissues tested (see Table II ).
The contribution of mHags to the cascade of inflammatory events, especially in cutaneous allo graft rejection, is largely dependent on which type of antigen presenting cell (APC) the antigen is presented on. Namely, T cells can be inactivated instead of activated when occupation of their T cell receptor (TCR) by antigen is not accompanied by appropriate co-stimulatory signal( s) . 1 9 This so called state of T cell anergy is marked by unrespon siveness to subsequent adequate triggering by professional APC and can be induced in several ways. 1 9 Keratinocytes, fibroblasts, and many other Table 1 and ref. 4) . The recognition of mHag HA-3 is restricted to HLA-A1.4 cPercentage specific lysis in the CML assay: <10% is negative, >11 % is scored as positive. dHLA specific CTL clones used in this study are directed against the HLA molecules HLA-A1 and HLA-A2.
so-called non-classical APC20 have been found to have no or little capacity of T cell activation, even after interferon-gamma induced HLA class II expression.2 1 •22 HLA class II expressing keratino cytes (also found in a GVHD-affected skin,20 were even found to tole rise hapten-specific T cell clones in vitro. 23 The expression of mHag on non-classical APCs, such as HA-3 on keratinocytes, could play a role in the induction of BM transplantation tolerance. We earlier investigated the development of acquired tolerance for mHag HA-3 in a healthy chima eric BM recipient 7 years after HLA-identical but HA-3 mismatched BMT.2 4 We found persistent host specific HA-3 expression on patient's skin tissue after BM transplantation together with disappear ance of anti-host HA-3 CTLs which paralleled the in vivo state of tolerance. We hypothesised, there fore, that direct presentation of host mHags by parenchymal host tissues functioning as non-classical or inadequate APC could result in tolerisation of anti-host CTLs induced following BM engraftment. 2 4 According to this hypothesis, the induction of long term graft-host tolerance versus graft-host reactivity after BM transplantation across mHags barriers would depend on the tissue distribution of the mHags in question.
Similarly, the need for adequate signals for T cell activation and subsequent murine corneal allograft rejection was earlier put forward by Chandler et al. 2 5 Indeed, inadequate presentation of the mHag H -Yin a murine cornea model led to a specific state of unresponsiveness to H_y2 6 On the other hand when the corneal graft, which is normally devoid of Langerhans cells (Le), became infiltrated with donor-derived LC through graft pretreatment with latex beads, rejection of mHag-disparate corneal grafts was observed.2 7 Although, as discussed above, keratinocytes are not capable of inducing primary T cell activation, they do have limited capacity to activate memory T cells. 2 8 In this context it is of importance to note that allogeneic corneas that were transplanted into eyes of presensitised mice were uniformly subjected to an acute rejection process?9 With regard to the role of mHag in the latter study, it was shown that the highest rate of rejection occurred among grafts that confronted their hosts with multiple mHag, with or without major histocompat ibility antigens? 9
mHag EXPRESSION ON HUMAN CORNEAL TISSUE: PRELIMINARY RESULTS
It is well known that corneal tissue recipients do benefit from an HLA matched graft,30 especially the high-risk patients?l Even in those HLA matched cases, corneal graft survival, after excluding the non immunological causes for graft failure, is well below lOO%?2 Since HLA antigens are expressed on corneal tissue,33 it would, in view of their character istics, not be surprising that mHags will coexist as well. To elaborate on the latter assumption, we recently started to analyse the functional expression of human mHags on corneal scleral tissue. Our well defined CTL clones specific major HLA antigens HLA-A1 and HLA-A2 and for the mHag H-Y (see Table. I) and for the non-sex-linked mHag HA-3 4 were used as effector cells in cell mediated lympholysis (CML) assays. As target cells, trypsi nised corneal scleral tissues were used. Table III demonstates the results of our first small series of experiments. Both HLA antigens and mHag H-Y and HA-3 are readily detectable on corneal tissue; they function as target molecules for CTL clones. These observations are in agreement with our earlier studies on the broad mHag tissue expression of H -Y and HA-3. Likewise, it is to be expected (Table II) , but has yet to be proven, that all mHag we can test for to date are expressed on LCs residing in the corneal epithelium. This knowledge is especially important in view of the LC's characteristic as an adequate APe. We demonstrate here for the first time, to our knowledge, the functional expression of mHags on human corneal tissue. Naturally these limited data need confirmation and extension. The present studies may bring us closer to understanding the impact of mHag mismatching between corneal graft donor and recipient in the human situation. The role of mHag disparities, in especially presensitised recipients, was recently clearly demonstrated in a murine study ? 9 Encouraged by the latter data we feel it is justified to continue our search for mHags on corneal tissue and their possible role in the outcome of corneal grafting. Key words: Cornea, Human, Minor histocompatibility antigens.
